| Symbol | CBLL |
|---|---|
| Name | CERIBELL, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Address | 360 N. PASTORIA AVENUE, SUNNYVALE, California, 94085, United States |
| Telephone | +1 800 436-0826 |
| Fax | — |
| — | |
| Website | https://www.ceribell.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients. Additional info from NASDAQ: |
📋 Woo Raymond (Officer) plans to sell 11K shares of Ceribell, Inc. (at $20.16 each, total $224K) Filed: May 01, 2026 | ID: 003195
Read moreNew Form ARS - Ceribell, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001193125-26-163307 <b>Size:</b> 2 MB
Read moreNew Form DEFA14A - Ceribell, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001193125-26-163300 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - Ceribell, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001193125-26-163290 <b>Size:</b> 3 MB
Read moreChao Xingjuan 🟡 adjusted position in 39.0K shares (2 derivative) of Ceribell, Inc. (CBLL) at $18.40 Transaction Date: Apr 06, 2026 | Filing ID: 147014
Read more📋 Chao Xingjuan (Officer) plans to sell 39K shares of Ceribell, Inc. (at $18.40 each, total $718K) Filed: Apr 06, 2026 | ID: 002800
Read moreChao Xingjuan 🟢 acquired 260.1K shares (1 derivative) of Ceribell, Inc. (CBLL) at $18.50 ($3.0M) Transaction Date: Apr 01, 2026 | Filing ID: 141908
Read moreBlumberg Scott 🟢 acquired 82.0K shares (1 derivative) of Ceribell, Inc. (CBLL) at $18.50 Transaction Date: Apr 01, 2026 | Filing ID: 141904
Read moreFoehr David 🟢 acquired 58.8K shares (1 derivative) of Ceribell, Inc. (CBLL) at $18.50 Transaction Date: Apr 01, 2026 | Filing ID: 141901
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |
| Ceribell EEG System | Other | Preclinical | Delirium in the Intensive Care Unit | RECRUITING | NCT07485244 |